LPCAT2 and metabolic dysfunction-associated steatohepatitis: Interestingly, there was a significant increase in Lpcat2 (4‐fold) and cPla2 (3‐fold) for the mice that developed NASH (32‐week WD), whereas no change in Alox15 was observed across groups (Fig. 7C).